Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Recruiting · NCT06496243 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic disease | Recruiting | Phase 2 | 2026-04-09 | NCT06496243 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NewAmsterdam Pharma | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UPenn | Philadelphia | United States | 5 |